Viewing Study NCT07432295

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-04-14 @ 6:07 AM
Study NCT ID: NCT07432295
Status: RECRUITING
Last Update Posted: 2026-02-25
First Post: 2026-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Sponsor: I-Mab Biopharma US Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
None Advanced Cancer View
None Metastatic Cancer View
None Gastric Cancer View
None Gastroesophageal Junction Carcinoma View
None Esophageal Adenocarcinoma View
Keywords: